Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04263584
Title Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL (COPA-R-CHOP)
Acronym COPA-R-CHOP
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Muenster
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital RWTH Aachen Aachen 52074 Germany Details
Klinikum-Bremen-Mitte Bremen 28205 Germany Details
St.-Johannes-Hospital Dortmund Dortmund 44137 Germany Details
Onkozentrum Dresden Dresden 01127 Germany Details
University Hospital Halle Halle (Saale) 06120 Germany Details
Westpfalz-Klinikum Kaiserslautern 67655 Germany Details
ÜBAG MVZ Dr. Vehling-Kaiser GmbH Landshut 84036 Germany Details
University Hospital Leipzig Leipzig 04103 Germany Details
University Hospital Muenster Muenster 48149 Germany Details
Hospital of the Ludwig-Maximilians-University (LMU) Munich Munich 81377 Germany Details
Hospital Stuttgart - Stuttgart Cancer Center Stuttgart 70174 Germany Details
University Hospital Ulm Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field